1015263

Ultragenyx Pharmaceutical Inc. — FEI 3012208691

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 20, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Novato, CA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol
748221 CFR 312.50General responsibilities of sponsors